Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Update on osteoporosis treatment. Should you stay on bisphosphonate drugs long-term?

[No authors listed]

Harv Womens Health Watch. 2012 Aug;19(12):6. No abstract available.

PMID:
23033551
2.

Boning up on osteoporosis medications.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2010 May;22(3):1-2, 7. No abstract available.

PMID:
20518136
3.

Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back.

Salari P, Abdollahi M.

J Pharm Pharm Sci. 2012;15(2):305-17. Review.

4.

Oral bisphosphonates and osteonecrosis of the jaw.

Wynn RL.

Gen Dent. 2007 Jan-Feb;55(1):8-10. Review. No abstract available.

PMID:
17333956
5.

Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

Ruggiero SL, Fantasia J, Carlson E.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct;102(4):433-41. Epub 2006 Jul 31. No abstract available.

PMID:
16997108
6.

Bisphosphonate therapy and dental treatment.

Phillips G.

J Indiana Dent Assoc. 2007-2008 Winter;86(4):4-8. No abstract available.

PMID:
18363257
7.

[Jaw necrosis following treatment with biphosphonates--the dose is of crucial significance for the risk].

Langdahl BL, Hitz M, Melsen B, Pinholt EM.

Ugeskr Laeger. 2009 Mar 23;171(13):1103; author reply 1103. Danish. No abstract available.

PMID:
19330957
8.

[Diphosphonate therapy and osteonecrosis of the jaw].

L√łkken P, Skoglund LA, Skjelbred P.

Tidsskr Nor Laegeforen. 2007 Aug 9;127(15):1945-7. Review. Norwegian. No abstract available.

9.

Treating osteoporosis.

Smith G, Stassen L, Flint S.

Ir Med J. 2009 Mar;102(3):88; author reply 89. No abstract available.

PMID:
19489199
10.

Osteoporosis treatments and adverse events.

Solomon DH, Rekedal L, Cadarette SM.

Curr Opin Rheumatol. 2009 Jul;21(4):363-8. doi: 10.1097/BOR.0b013e32832ca433. Review.

PMID:
19412101
11.
12.

Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.

Jimenez-Soriano Y, Bagan JV.

Med Oral Patol Oral Cir Bucal. 2005 Jul 1;10 Suppl 2:E88-91. English, Spanish. No abstract available.

13.

Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw.

Lewis DM.

J Okla Dent Assoc. 2011 Jul-Aug;102(5):36-9. No abstract available.

PMID:
21874699
14.

[Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered].

Mawatari T.

Clin Calcium. 2010 Nov;20(11):1743-7. Review. Japanese. No abstract available.

PMID:
21066910
15.

[Bisphosphonate-associated osteonecrosis of the jaws 1].

Allard RH, Lips P, Eekhoff EM, van Merkesteyn JP, van der Waal I.

Ned Tijdschr Tandheelkd. 2007 Oct;114(10):423-7. Dutch.

PMID:
17972610
16.

I've heard that bisphosphonate medications used for osteoporosis can affect a person's jaw. Can you tell me more?

[No authors listed]

Mayo Clin Womens Healthsource. 2008 Sep;12(9):8. No abstract available.

PMID:
18667975
17.

Oral bisphosphonates and osteonecrosis of the jaw: are the MHRA recommendations appropriate?

Compston J.

Menopause Int. 2007 Jun;13(2):54-5. No abstract available.

PMID:
17540133
18.

Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?

Fusco V, Baraldi A, Loidoris A, Ciuffreda L, Galassi C, Goia F, Scoletta M, Berrone S, Benech A, Ortega C, Berruti A; Rete Oncologia di Piemonte e Valle d'Aosta ONJ Study Group.

J Oral Maxillofac Surg. 2009 Aug;67(8):1775. doi: 10.1016/j.joms.2009.03.061. No abstract available.

PMID:
19615599
19.

Managing the adverse effects of bisphosphonate therapy on the jaw.

Rizzolo D, Sedrak M.

JAAPA. 2009 Nov;22(11):48-52. No abstract available.

PMID:
19999176
20.

Osteonecrosis of the jaw after oral bisphosphonate for osteoporosis.

Tong CK, Ho ST, Wong SL.

Hong Kong Med J. 2010 Apr;16(2):145-8.

Supplemental Content

Support Center